Chelidonium majus L. (Ukrain) in the treatment of cancer patients.

Abstract

Ukrain, a semi-synthetic thiophosphoric acid compound of alkaloid chelidonine isolated from Chelidonium Majus L., Tris(2-([5bS-(5ba,6b,12ba)]-5b,6,7,12b,13,14- Hexahydro-13-methyl][1,3]-benzodioxolo[5,6-c]-1,3-dioxolo[4, 5- i]phenanthridinium-6-ol]-Ethaneaminyl) Phosphinesulfide 6HCl, causes a regression of tumours and metastases in many oncological patients. More than 400 documented patients with various carcinomas in different stages of development have been treated with Ukrain. The authors report on only three different cases treated with preparation Ukrain. Ukrain can be helpful in improving the general condition and prolonging life by reduction of the tumour progression and its immunomodulating effect on the organism.

• Authors: A Lohninger, F Hamler
• Journal: Drugs under experimental and clinical research (Drugs Exp Clin Res) Vol. 18 Suppl Pg. 73-7 ( 1992) ISSN: 0378-6501 [Print] Switzerland
• PMID: 1305049 (Publication Type: Case Reports, Journal Article)

Chemical References

• Alkaloids
• Antineoplastic Agents, Phytogenic
• Berberine Alkaloids
• Phenanthridines
• ukrain

Topics

• Adenocarcinoma (drug therapy)
• Aged
• Alkaloids (adverse effects, therapeutic use)
• Antineoplastic Agents, Phytogenic (adverse effects, therapeutic use)
• Berberine Alkaloids
• Bone Neoplasms (diagnostic imaging, drug therapy, secondary)
• Breast Neoplasms (complications, drug therapy)
• Child
• Colonic Neoplasms (drug therapy)
• Female
• Humans
• Middle Aged
• Neoplasms (diagnostic imaging, drug therapy)
• Phenanthridines
• Radiography
• Sarcoma, Ewing (diagnostic imaging, drug therapy)